Long-Term Outcomes with Sequential Tyrosine Kinase Inhibitors Treatment in Chronic Myeloid Leukemia Patients.

Saikhuan TowachirapornaTeerachat Punnachet Nonthakorn Hantrakun Pokpong Piriyakhuntorn Thanawat Rattanathammethee Sasinee HantrakoolChatree Chai-AdisaksophaEkarat Rattaritamrong Lalita Norasetthada Adisak Tantiworawit

Published in: Asian Pacific journal of cancer prevention : APJCP (2023)

The sequential treatment for CML patients had a good response. Factors predicting survival were ELTS score, ECOG performance status, and early achieving MMR and CCyR.

Keyphrases

end stage renal disease
chronic myeloid leukemia
ejection fraction
newly diagnosed
prognostic factors
combination therapy
free survival